SUPPORTING MATERIAL
StemChecker: a web-based tool to discover and explore stemness signatures in gene sets José Case Study Details:
Gene sets for pancreatic ductal adenocarcinoma
To illustrate the utility of StemChecker in examining human diseases such as cancer, we collected two gene sets associated with pancreatic ductal adenocarcinoma (PDAC). The first gene set was derived by Haider and co-workers based on a meta-analysis of transcriptome data from 466 patients [S1] . It includes 225 genes which are prognostic for patient survival time (data set accessible at http://genomemedicine.com/content/supplementary/s13073-014-0105-3-s2.xls).
For 180 of 225 genes, an increase in expression predicts shorter survival time. We input these 180 genes into StemChecker, which identified 170 genes in its underlying database. Strikingly, more than a third of these genes (59) were found in stemness signatures for embryonic stem cells (adjusted pvalue = 3.99x10 -8 , see Table S1 ). In contrast, inputting the 45 genes whose down-regulation is linked to a shorter survival time did not yield any significant enrichment among integrated stemness signatures associated with the different stem cell types (Table S2 ) or in any individual stem cell signature (data not shown). We also re-analyzed a study comparing the expression profiles of 45 matching pairs of tumor and adjacent non-tumor tissue samples from resected PDAC cases [S2] . The original expression data can be accessed at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28735. To identify differential expression between tumor and non-tumor samples, we utilized GEO2R (http://www.ncbi.nlm.nih.gov/geo/geo2r/?acc=GSE28735). Using the default settings and Benjamini-Hochberg correction, we obtained 880 genes up-regulated in PDAC compared to pancreatic tissue with adjusted pvalue < 10 -5 . Of these, StemChecker found 752 genes in the database.
In total, 752 were identified in the database. Significant enrichment was obtained for several types of stem cells ( Figure S3 and Table S3 ). The most significant enrichment of up-regulated genes was detected among the integrated signatures for ESCs (7.8x10 -8 ) followed by those for embryonal carcinomas (3.8x10 " 5" Figure S3 : The radar chart shows the enrichment of genes up-regulated in PDAC among integrated stemness signatures for different types. 
In vitro differentiation of mESCs
In the study by Gaspar and co-workers, in vitro differentiation of CGR8 ESC gene expression was profiled by microarray measurement in the first 10 days [S3] . CGR8 is a cell line that was established from the inner cell mass of a 3.5 day male pre-implantation embryo (Mus musculus, strain 129). The study comprises 27 samples taken at different time points (0, 1, 2, 3, 4, 5, 6, 7, 10 days) in triplicates. The microarray data was retrieved from EBI ArrayExpress (ETABM-672) and background correction, normalization and summarization of gene expression (using RMA as implemented in the affy package in R) was carried out. Differentially expressed genes were detected with the "limma" package in R, comparing Day0 vs All remaining time points (i.e. day 1, 2, 3, 4, 5, 6, 7, and 10) and Day3 vs all remaining time points. To obtain a list of up-regulated genes at time point 0 (i.e. for undifferentiated ESC) and at day 3 (for embryoid bodies), we extracted all positively regulated genes with an adjusted pvalue < 10 -5 at the two time points. This resulted in 561 up-regulated genes at day 0 and 94 up-regulated genes at day 3. The enrichment in TF target genes sets is displayed in supporting tables S4 and S5. Mm_Myc_Kidder 1452 54 9.328E-7 6.809E-5 Table S6 : Statistics for the overlap of genes up-regulated at day 3 with TF target gene sets. Only results with adjusted pvalue < 10 -5 are displayed.
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